Patients on Levodopa Can Prolong ‘On-Time’ with Opicapone, Phase 3 Trials Show – Parkinson’s News Today

Patients on Levodopa Can Prolong ‘On-Time’ with Opicapone, Phase 3 Trials Show – Parkinson’s News Today
Patients on Levodopa Can Prolong 'On-Time' with Opicapone, Phase 3 Trials Show  Parkinson's News TodayOnce-daily opicapone can prolong the time during which treatment with levopoda, a standard therapy, effectively prevents motor symptom fluctuations in people ... read more
Source: Google NewsPublished on 2019-05-06